Japan's health names latch onto Vietnam
Japanâs health names latch onto Vietnam 14:00 | 05/02/2021 Vietnamâs healthcare expenditures reached around $17 billion in 2019, photo Le Toan The second-largest pharmaceutical company in Japan, Daiichi Sankyo Co., Ltd., has entered a licence agreement with Mitsubishi Tanabe Pharma Corporation to register and launch edaravone brand Radicava in Vietnam. The medication treats patients with amyotrophic lateral sclerosis and helps with recovery from a stroke. Yukinori Tominaga, general director of Daiichi Sankyo Vietnam Co., Ltd., told VIR, âWe are g...
Source: vir.com.vn